Marketresearchnews: November 2020

Monday, 30 November 2020

Hypotension Treatment Market 2023 Forecasts By Global Industry Analysis In 2020 Report

The worldwide low blood pressure or hypotension market is driven by various factors. Some of these comprise rising hypotension cases, aged population, cardiovascular illnesses, & diabetics. Dehydration, endocrine disorders, and nerve issues can also cause hypotension, leading to further market growth. Low blood pressure patients often feel dizzy and weak, which is why, they are recommended several medicines to maintain stability and good health.

Teenagers and post-partum mothers are also impacted by hypotension. Moreover, sedentary & bad eating habits contribute to the development of lifestyle diseases, adding to the demand for better treatments. Medicines prescribed for hypotension can have serious side effects. However, these can be fought on account of proper guidance and patient-suitability. Awareness about hypotension and the demand for innovative cardiac instruments also propel market revenues.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5628

Developments across various technologies and entry of new companies should also boost market size in the forecast period. The 3 key factors that hamper the industry are the existence of alternative treatments, shortage of experts, and costly cardio diagnosis & treatments. The presence of cardiac & diabetic patients has increased stress on developing & developed nations. The hypotension treatment market is segmented on the basis of products, indications, applications, and regions.

Blood pressure instruments, blood pressure transducers, and sphygmomanometers constitute the products. Hypotension, cardiovascular disorders, and others form the indications. Application sectors comprise homecare, diagnostic centers, clinics, laboratories, hospitals, etc. Different regions across which the market is spread contain Asia Pacific, Americas, Europe, and the Middle East and Africa.

Geographical Details and Prominent Firms

“Americas” is the largest market, with its huge diabetic & coronary disease base driving its incomes. Asia Pacific should be observing the highest CAGR over the forecast period. Europe followed Americas in terms of the size. According to a study by MRFR (Market Research Future), the Middle East and Africa is expected to undergo steady expansion, due to the need for advanced therapeutic centers & diagnostic procedures.

Some of the eminent companies spending capital on the hypotension treatment industry are Shire plc, Hoffman-La Roche Limited, and Amgen, Inc. They make use of various strategies to gain shares and maintain competitiveness over other firms. These strategies consist of, but are not restricted to partnerships, acquisitions, mergers, and product launches.

Key Findings and Innovative Trends

The cardiovascular (hypotension) pipeline has assisted with tracking & recognizing new participants & their products. The said factor has widened the reach of hypotension treatments & helped make better decisions. A novel drug, Droxidopa, sold as Northera, was sanctioned to manage multiple-system atrophy, Parkinson’s disease, and pure autonomic failures. The authorization was done in view of 2 laboratory experiments.

In both these trials, patients consuming Droxidopa capsules for two weeks, benefitted with regards to feeling less dizzy & light-headed. Headache, nausea, and dizziness were some of the general side effects observed from these capsules. The drug would highlight the risk of hypertension in the horizontal position. Blood pressure in the horizontal position can be recorded before & during the therapy. The need for better hypotension medicines & therapies across end-user industries will also steer product developments in the near future.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hypotension-treatment-market-5628

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Eye Melanoma Market Set For Big Growth - Foresight By 2023

Market Highlights

Increasing prevalence of the eye cancer, growing geriatric population, rising healthcare expenditures, and increasing research and development investments by the major players of the market are the major driver for the market growth. On the other hand factors such as lack of awareness, high diagnostics, and surgical procedures costs are projected to restrain the market growth during the estimated period. Laser iridotomy is estimated to cost around USD 1,068 to USD 1,188.

Segmentation

The global eye melanoma market is segmented on the basis of the site, diagnosis, treatment, and end user.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5570

On the basis of the site, the market is segmented into sclera, retina, uvea, and others. On the basis of the diagnosis, the market is categorized into eye exam, imaging, biopsy, and others. The eye exam segment is sub-segmented into ophthalmoscopy, slit-lamp biomicroscopy, and others. The imaging segmented is sub-segmented into ultrasound, fluorescein angiography, fundus autofluorescence, optical coherence tomography, and others. On the basis of the treatment, the market is segmented into radiation therapy, laser treatment, surgery, and others. The radiation therapy segment is sub-segmented into episcleral plaque therapy, external beam radiation therapy, and others. The surgery segment is sub-segmented into iridectomy, choroidectomy, enucleation, and others. On the basis of end users, the market is segmented into hospitals & clinics, academic institutes, and others.

Regional Analysis

America dominates the global eye melanoma market. The presence of a well-developed healthcare sector, huge patient population, changing lifestyle, and increasing health care expenditure are major drivers of the Americas market. Europe is the second leading region in the global eye melanoma market due to increasing availability of funds for research, well-developed healthcare sector, huge patient and growing geriatric population. The European region is bifurcated into Western Europe and Eastern Europe. Western Europe leads the market due to the presence of the developed economies, for instance, the U.K, France, and Italy. The Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, and rising healthcare expenditure. The Middle East & Africa owns the least share of the global eye melanoma market due to the presence of poor economies and stringent government policies, especially in the African region. The Middle East holds a majority of the market due to a well-developed healthcare sector and huge healthcare expenditure by economies like Dubai, Kuwait, Dubai, and others.

Key Players

The key players for the global eye melanoma market are Castle Biosciences, Inc. (U.S.), GENERAL ELECTRIC (U.S.), Koninklijke Philips N.V. (The Netherlands), TOSHIBA CORPORATION (Japan), Siemens AG (Germany), Analogic Corporation (U.S.), Optovue, Incorporated (U.S.), NOVADAQ Technologies Inc. (Canada), Agfa-Gevaert Group (Belgium), ZEISS (Germany), and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eye-melanoma-market-5570

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Ovarian Cysts Market Segmentation And Analysis By Recent Trends And Growth Prospects By Regions To 2023

Global Ovarian cysts Market – Overview

Ovarian cysts are closed, sac-like structures filled with a liquid or semisolid substance within the ovary. These cysts are usually reported in the ovulating females and generally do not cause any medical complication. However, menopausal development of the ovarian cysts is also possible. In such conditions, the risks of ovarian cancer increases.

Ovarian cysts is a condition with high risks for ovarian cancer. Most of these cysts are discovered during a routine pelvic exam. As per a study published by the Journal of Clinical Research in Paediatric Endocrinology in 2017, the frequency of ovarian cysts is about 1.8% in children aged between 5-9 years and 18.8% in those who aged between 10-18 years. Furthermore, it is estimated that with the onset starts from adolescence and as the age increases the frequency of ovarian cysts increases with a ranges between 3.8 %- 31.3%. Such trends in the prevalence of the ovarian cysts are one of the major factors driving the market growth. Moreover, rising healthcare expenditures and increasing awareness about woman health boost the market growth. However, lack of awareness and low per capita healthcare expenditure in the developing countries may restrain the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1784

Globally the ovarian cysts market is expected to grow at the rate of about 8.2% from 2016 to 2022.

Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (The Middle East & Africa), Quest Diagnostics Incorporated. (U.S.), Novartis AG (Europe), General Electric Company (Europe), Merck & Co., Inc. (U.S.), Boston Scientific Corporation (U.S.), and Medtronic (U.S) and others are some of the prominent players at the forefront of competition in the global ovarian cysts market and are profiled in MRFR Analysis.

Industry Updates

January, 2016 Teva Pharmaceutical Industries Ltd., announced the launch of a generic equivalent of Ortho Tri-Cyclen Lo tablets in the United States. This drug launch will expand Teva’s women’s health drug portfolio for U.S.

Jan, 2013 Lupin receives FDA approval to market generic Lutera Tablets to market a generic version of Watson Laboratories, Inc.’s Lutera 28 Tablets.

Global Ovarian cysts Market – Regional Analysis

Global Ovarian cysts market, on the basis of regions is divided into Americas, Europe, Asia Pacific and Middle East and Africa.

The Americas holds the largest share of the global ovarian cysts market. Increasing prevalence of the disease, rising per capita healthcare expenditure and increasing awareness for the woman health are some of the major drivers of the market growth within the region. In 2015, according to the Centres for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. Moreover, developed healthcare sector and availability of huge funds research and development boosts the market growth. However, late diagnosis, and lack of awareness may restrain the market growth during the forecast period. North America dominates the Americas ovarian cysts market due the presence of market players such as Quest Diagnostics Incorporated and Medtronic along with the developed economies like the U.S. and Canada within the region. However, South America shows the fastest growth in the market due to the presence of huge opportunities for the development of the market.

Europe is the second largest ovarian cysts market, which is followed by Asia Pacific. Availability of funds for research, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development are projected to drive the market growth during the forecasted period. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe holds the major share of the regional market, which is majorly contributed by Germany, the U.K., and France. However, Eastern Europe is the fastest growing region due to the huge opportunities in the untapped market.

Asia Pacific is the fastest growing region in the global the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. Moreover, favorable government policies and increasing healthcare expenditures fuel the market growth within the region.

On the other hand, the Middle East & Africa holds the least share of the global ovarian cysts market due to the presence of poor economy, especially, in the African region. Majority of the market of this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure by the presence of economies like Kuwait, Saudi Arabia, Dubai, and Qatar.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ovarian-cysts-market-1784

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Needle Market 2023 Forecasts By Global Industry Analysis In 2020 Report

Market Scenario:

The healthcare sector have been expanding over years and dentistry is not an exception. The increasing demands for dentistry have created favourable backgrounds for dental needle market to grow. Structurally, a dental needle have four major components- bevel, shank, hub, syringe adaptor, and cartridge penetration end. Increasing prevalence of dental conditions like periodontal disease, caries, besides others and rising dental-healthcare expenditure majorly drives the market growth. According American Society for Nutrition in 2016, 47 % of the adults in the U.S. have periodontal disease. Moreover, according to the American Dental Association, the U.S. national dental expenditures rose from USD 114 billion in 2014 and reached USD 117.5 billion in 2015. Additionally, growing geriatric population fuels the market growth. According to the report of WHO published in 2015, the geriatric population is expected to double and reach 2.1 billion by 2050. However, introduction of needleless delivery systems and risks of infection may restrain the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/890

The global dental needle market is expected to grow at an approximate CAGR of 5.4% during the forecast period.

Intended Audience

Healthcare companies
Biotechnological institutes
Research and Development (R&D) Companies
Medical Research Laboratories
Market Research and Consulting Service Providers

Segmentation

The global dental needle market is segmented on the basis of type, gauge, length, and end users, and others.

On the basis of type, the market is segmented into plastic hub dental needle, anaesthetic dental needle, by bevel design, and others. On the basis of bevel design the market is sub segmented into regular bevel needle, triple bevel needle, scalpel-designed bevel needle, and others.

On the basis of gauge, the market is categorised into 25G, 27G, 30G needle, and others. On the basis of length, the market is segmented into 8mm, 16mm, 22mm needle and others. On the basis of end users, the market is segmented into hospitals, clinics, academic institutes, others.

Regional Analysis

America dominates the global dental needle market owing to a well-developed healthcare sector and high per capita healthcare expenditure. Moreover, high prevalence of dental diseases, increasing boosts the growth of the market in America. Additionally, the presence of developed economies like U.S. and Canada and global players such as Dentsply Sirona. and MEDTRONIC within the regional boundaries fuels the market growth.

Europe is the second large market for dental needle, which is followed by Asia Pacific. Availability of funds for research, well developed healthcare infrastructure, huge patient population, rising healthcare expenditure and government support for research & development will drive the market in the Europe.

Asia Pacific is the fastest growing region for the market due to the presence of developing economies like India and China within the region which have increasing healthcare expenditures. This along with favourable government policies and growing geriatric population will boost the market growth in the presence of huge opportunity for the untapped market within the region. According to the Economic and Social Commission for Asia and the Pacific, in 2016 about 12.4% of the population within the region aged 60 or more. This geriatric population is expected to reach 1.3 billion by 2050.

The Middle East & Africa has the least share in the global dental needle market due to presence of poor economies especially in the African region. Majority of the market of Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait and Qatar within the region.

Key players for global dental needle market

The key players for the global dental needle market are Septodont (Europe), Dentsply Sirona. (U.S.), Shinhung Co., Ltd (Asia Pacific), NIPRO Medical Corporation (U.S.), TERUMO CORPORATION (Asia Pacific), MEDTRONIC (U.S.), J. MORITA CORP. (Asia Pacific), EXELINT International, Co. (U.S.), TSK Laboratory Europe B.V. (Asia Pacific), and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-needle-market-890

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

North America Dental consumables Market Growth Factors, Types And Application By Regional Analysis 2023

North America Dental Consumables Market- Overview

The North America Dental Consumables Market is growing with a rapid pace. According to a recent study report published by the Market Research Future, the North America Dental Consumables Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017-2023).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4612

Dental Consumables are a category of products that are used on patients by dental practioners or dentists in order to treat and /or perform procedures associated with preventive, restorative, diagnostic and emergency oral health issues. Factors such as increasing prevalence of dental diseases and rising number of dental procedures are the major drivers for the market growth. According to the American Dental Association, in 2014, 52.3% of adults reported to visit the dentist in every six months, 15.4% reported once per year, and 11.0% reported once every two to three years. Moreover, according to the Centres for Disease Control and Prevention, in 2014, 19% of the children aged 5-19 years and 31% of adults aged 20-44 have untreated dental caries. Additionally, growing geriatric population is fuelling the market growth. However, poor reimbursement policies and gray market of dental distribution are estimated to restrain the market growth during the forecast period. According to the National Coalition on Health Care, in 2012, American families spent an average of USD 9,000 on out-of-pocket health insurance and other medical costs like co-pays and deductibles.

North America Dental Consumables Market- Competitive Analysis

Institut Straumann AG, Henry Schein, Inc., Patterson Dental Supply, Inc., Dentsply Sirona, Kerr Corporation, Danaher Corporation, GC orthodontics, Planmeca Oy, and American Orthodontics, and others are some of the prominent players at the forefront of competition in the North America Dental Consumables Market and are profiled in MRFR Analysis.

Characterized by the presence of several well-established and small players, the North America Dental Consumables Market appears to be highly competitive and fragmented. International players are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In August, 2016- Henry Schein announced that it will acquire 80% ownership of Marrodent, which is a full service dental distributer of Poland, thus marking Henry Schein’s entry into the dental market of Poland.

In July, 2016- Kitron signs supply agreement with Dentsply Sirona. This agreement will add Kitron as a new supplier for Dentsply Sirona.

In April, 16- Straumann acquired 51% residual ownership of Neodent. This deal augments Straumann’s presence in the tooth replacement sector in the Latin American region and Brazil, which is the second largest market for implant dentistry.

In February, 16- Septodont signed an agreement with Egalet Corporation, a specialty pharmaceutical company, for exclusive marketing rights to promote Sprix nasal spray to the dental market in the United States.

In May, 16- Knifeless Tech Systems was acquired by 3M. The business acquired is an installation tool used to cut self-adhesive films applied to vehicle wraps.

In February, 16- Septodont acquired DLA, an injectable dental anaesthetic manufacturing plant from Dentsply International.

In February, 16- DENTSPLY International Inc. and Sirona Dental Systems, Inc. Announce Completion of Remaining Regulatory Milestones for Proposed Merger.

North America Dental Consumables Market- regional analysis

Regionally, North America is divided into the U.S. and Canada. The U.S. is estimated to lead the North America Dental Consumables Market owing to high expenditure on the health care within the region. Moreover, the fastest uptake of new products in the U.S drives the dental consumables market. Additionally, concentration of the major healthcare companies in the developed economies of this region coupled with large insurance penetration is also adding fuel to the market growth.

FOR MORE DETAILS –https://www.marketresearchfuture.com/reports/north-america-dental-consumables-market-4612

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

EMEA Blood Glucose Test Strip Market Growth Factors, Types And Application By Regional Analysis 2021

Market Highlights

In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Europe, the Middle East and Africa Blood Glucose Test Strip Packaging Market. We are thankful for the support and assistance from Europe, the Middle East and Africa Blood Glucose Test Strip Packaging Market chain related technical experts and marketing experts during Research Team survey and interviews.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/601

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of The Study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.3 Growth Barriers

4.4 Growth Opportunities

4.5 Macroecnomical Indicators

5 Market Analysis

6 Europe, The Middle East And Africa Blood Glucose Test Strip Market

6.1 Introduction

6.2 By Volume

6.3 By Value

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/europe-blood-glucose-test-strip-packaging-market-601

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Point of Care Technology Industry Growth, Trends And Forecast Till 2023 By Marketresearchfuture.Com

Market Highlights

Point of care technology is termed as a time when clinicians deliver healthcare products and services to patients. Point of care technology includes diagnostics, devices for documentation, and others. Point of care documentation devices smooth the workflow, reduces errors in a clinical tasks including diagnostics, medication prescribing, and medication administration, which will indirectly boost the growth of the market. Moreover, increasing prevalence of the diseases and rising research and development facilities. Furthermore, rising healthcare expenditure, and increasing awareness among the people regarding the point of care diagnostics products, are some of the factors that are expected to fuel the market growth. On the other hand, higher cost of the point of care technology is may affect the growth of the market negatively during the forecasted period. Moreover, development in the diagnosis of patients with chronic diseases, for instance, diabetes, and growing medical technology are likely to increase the growth of the market. In point of care technology, it provides ease of diagnosis where the patient is seen at home. The point of care testing devices in the healthcare focuses on quality rather than test volume, which is expected to boost the growth of the market over the review period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1164

Complexity of documentation in the point of care technology may hinder the growth of the market during the forecasted period.

The global point of care technology market is expected to grow at a CAGR of 9.5% during the forecast period 2017–2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 100 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “point of care technology market research report–Global forecast till 2023.”

Major Players in Point of care technology Market

Some of the key players in the global market are Abbott (U.S.), Johnson & Johnson Services, Inc.(U.S.), Techno MedicaCo., Ltd. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Beckman Coulter, Inc. (U.S.) BD (U.S.), Quidel Corporation (U.S), Meridian Bioscience, Inc. (U.S).

Regional Analysis

The global point of care technology market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas accounts for a significant share of the global point of care technology market as a result of the presence of huge & increasing patient population base and the largest producer and consumer of medical devices. Similarly, the demand for medical devices in Europe is expected to increase growth of the market positively. Europe holds the second position in the global market, which is followed by Asia Pacific. Asia Pacific may experience the growth owing to the presence of abundant opportunities for medical device manufacturers. For instance, healthcare services revenue is increasing rapidly, especially, in India and China, which is predicated to result in a large number of new hospital construction projects.

Whereas, the Middle East & Africa holds the least share in the global point of care technology market on account of poor economic condition and less development in healthcare infrastructure.

Segmentation

The global point of care technology is segmented by type of products, and end users. On the basis of type of product, it is segmented into glucose testing, cardiac markers, HbA1c testing, and coagulation, and others. On the basis of end users, it is segmented into clinics, hospital, home care, ambulatory care, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

High Intensity Focused Ultrasound Market Forecasts By Industry Drivers, Regions Till 2023

Market Highlights

High-intensity focused ultrasound (HIFU) therapy is a novel, emerging, and therapeutic modality technology. It involves propagation of ultrasound waves through cancerous tissues that kills cancer cells. HIFU is a minimal invasive technique and is performed with real-time imaging by ultrasound or MRI to enable treatment targeting and monitoring. This technology have been extensively exploited for the treatment of prostate, liver, pancreatic, and bladder cancer. The American Cancer Society estimated that about 161,360 new cases of prostate cancer have been registered in the US in 2017. Moreover, the number of people living beyond a cancer diagnosis were nearly 14.5 million in 2014 and is expected to rise to over 19 million by 2024. Moreover, increasing development in the medical technology and its wide range of application used in the treatment of uterine fibroids, neurological disorders, cosmetic medicine and others fuel the growth of this market. However, high cost of the treatment and certain adverse effects are likely to restrain the market growth over the forecasted period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/885

The global high intensity focused ultrasound (HIFU) therapy market is expected to grow at a CAGR of 7.8% during the forecast period 2017–2023.

Taste the market data and market information presented through more than 115 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “high intensity focused ultrasound (HIFU) therapy market research report–Global forecast till 2023.”

Major Players in High intensity focused ultrasound (HIFU) therapy Market

Some of the key players in the global market are Image Guided Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments.

Regional Analysis

The global high intensity focused ultrasound (HIFU) therapy market consists of four regions including the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global HIFU therapy market. North America is the largest market owing to rising prevalence of cancer cases in the American counties and well-developed technology in this region contributes majorly to the growth of this market.

Europe accounts for the second largest share of the global HIFU therapy market. In the Europe, wide demand for cancer diseases treatment methods drives the market growth. Moreover, increasing expenditure in the healthcare domain and investment in research & development in developing new treatment methods for cancer diseases will fuel to the growth of this market.

Asia Pacific is the fastest growing market in the world. India is the largest potential market due to increasing investments in healthcare services and increasing adaption of new technologies used for diagnosis and treatment methods.

The Middle East & Africa is expected to witness a steady growth due to rising demand for primary healthcare services such as new and advanced treatment methods in healthcare domain.

Segmentation

The global high intensity focused ultrasound (HIFU) therapy market has been segmented on the basis of modality, which comprises of therapeutic ultrasound, hemostasis, lithotripsy, thrombolysis, immunomodulation, and others. On the basis of the methods, the market is segmented into non-invasive method and minimal invasive method. On the basis of applications, the market has been segmented into prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others. On the basis of end users, the market has been segmented into diagnostic centers, hospitals, research centers, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/high-intensity-focused-ultrasound-therapy-market-885

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com